SA
Safilo Group S.p.A.
SAFLF · OTC
$2.58 +0.00% (+$0.00)
Market Cap 635.1M €
P/E Ratio 9.25x
Div. Yield -
ROE 17.88%
Bulios Fair Price
$2.14
17.1% downside
Current Price
$2.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SAFLF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
100 /100
Cheap EV/EBITDA 4.14x
P/S 0.35x
P/B 1.58x
Growth
46 /100
Stable Book val. growth 6.22%
Rev. growth 4.67%
FCF growth N/A
Profitability
48 /100
Moderate Net margin 4.05%
Op. margin 6.07%
FCF margin 6.31%
Quality
83 /100
Excellent ROE 17.88%
ROA 9.09%
Asset turnover 2.24x
Debt
99 /100
Low Current ratio 1.86x
Int. coverage 15.89x
Net debt/EBITDA 0.26x
Stability
62 /100
Moderate Rev. volatility 21.02%
EPS volatility 29.16%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SAFLF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Angelo Trocchia
Employees
3,400
Headquarters
Padua
Upcoming events
16 MAR
Earnings
Upcoming earnings report